Covishield Vaccine Trial

Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.

The participants in the clinical trials of Covishield and Covaxin have received their Covid vaccination certificates through the CoWIN app, the Centre has said. Union Health Minister Mansukh Mandaviya thanked their contribution during the pandemic.

Once the results of Covaxin's phase 3 trials are out in July, its manufacturers have scheduled a phase 4 trial to test the vaccines real-world effectiveness, Bharat Biotech said today.

Russian-made Coronavirus vaccine Sputnik -- peer-reviewed by the Lancet Medical Journal -- is undergoing trials in India and could be available for use soon. "I believe the vaccine should be available in India from March- April," Deepak Sapra, the chief of API and pharma services at Dr Reddy's Laboratories, which is manufacturing the vaccine, told...

The president of the Karnataka Association of Resident Doctors, Dr Dayanand Sagar on Tuesday raised concern over the COVID-19 vaccine Covaxin.

Resident doctors at one of Delhi's biggest healthcare hubs, the Ram Manohar Lohia Hospital, on Saturday demanded they be administered Covishield vaccine and not Covaxin since the former has completed all three stages of trials as required under protocol. The second one, produced by Hyderabad-based Bharat Biotech, is still only undergoing stage-III ...

Bharat Biotech has enrolled 25,800 volunteers for phase 3 clinical trials of its COVID-19 vaccine, the company said today. The maker of Covaxin is one of the two firms cleared by the government to deploy their product for mass inoculation in the country. The other is Oxford-AstraZeneca's Covishield manufactured by the Serum Institute of India.

The Serum Institute responded to "malicious and mischievous" allegations by preparing a Rs 100 crore defamation suit against a coronavirus vaccine trial participant who claimed a "virtual neurological breakdown" after being given a dose

The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.

The Union Health Ministry has said it does not agree with the Rs 80,000 crore figure cited by Adar Poonawalla, CEO of Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting trials of Covid vaccine candidates ahead of mass production - for buying and distributing the vaccine in the country. The Mini...

Adar Poonawalla, the CEO of the Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting Covid vaccine trials ahead of mass production - took to Twitter to highlight potential challenges ahead of vaccine production and distribution

The civic-run King Edward Memorial (KEM) Hospital in Mumbai today began phase II and III trials of the Oxford Covishield vaccine for COVID-19, an official said.

The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University, and being manufactured by the Serum Institute of India (SII), will begin at the Sassoon General Hospital in Pune next week.

New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.

Serum Institute of India, which is manufacturing the coronavirus vaccine Covishield being developed by the Oxford University along with pharma major AstraZenca, today said it will stop the Phase 3 trials that were to begin in India next week. The vaccine trial was stopped across four nations as a precautionary measure after one of the recipients in...

Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.

The participants in the clinical trials of Covishield and Covaxin have received their Covid vaccination certificates through the CoWIN app, the Centre has said. Union Health Minister Mansukh Mandaviya thanked their contribution during the pandemic.

Once the results of Covaxin's phase 3 trials are out in July, its manufacturers have scheduled a phase 4 trial to test the vaccines real-world effectiveness, Bharat Biotech said today.

Russian-made Coronavirus vaccine Sputnik -- peer-reviewed by the Lancet Medical Journal -- is undergoing trials in India and could be available for use soon. "I believe the vaccine should be available in India from March- April," Deepak Sapra, the chief of API and pharma services at Dr Reddy's Laboratories, which is manufacturing the vaccine, told...

The president of the Karnataka Association of Resident Doctors, Dr Dayanand Sagar on Tuesday raised concern over the COVID-19 vaccine Covaxin.

Resident doctors at one of Delhi's biggest healthcare hubs, the Ram Manohar Lohia Hospital, on Saturday demanded they be administered Covishield vaccine and not Covaxin since the former has completed all three stages of trials as required under protocol. The second one, produced by Hyderabad-based Bharat Biotech, is still only undergoing stage-III ...

Bharat Biotech has enrolled 25,800 volunteers for phase 3 clinical trials of its COVID-19 vaccine, the company said today. The maker of Covaxin is one of the two firms cleared by the government to deploy their product for mass inoculation in the country. The other is Oxford-AstraZeneca's Covishield manufactured by the Serum Institute of India.

The Serum Institute responded to "malicious and mischievous" allegations by preparing a Rs 100 crore defamation suit against a coronavirus vaccine trial participant who claimed a "virtual neurological breakdown" after being given a dose

The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.

The Union Health Ministry has said it does not agree with the Rs 80,000 crore figure cited by Adar Poonawalla, CEO of Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting trials of Covid vaccine candidates ahead of mass production - for buying and distributing the vaccine in the country. The Mini...

Adar Poonawalla, the CEO of the Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting Covid vaccine trials ahead of mass production - took to Twitter to highlight potential challenges ahead of vaccine production and distribution

The civic-run King Edward Memorial (KEM) Hospital in Mumbai today began phase II and III trials of the Oxford Covishield vaccine for COVID-19, an official said.

The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University, and being manufactured by the Serum Institute of India (SII), will begin at the Sassoon General Hospital in Pune next week.

New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.

Serum Institute of India, which is manufacturing the coronavirus vaccine Covishield being developed by the Oxford University along with pharma major AstraZenca, today said it will stop the Phase 3 trials that were to begin in India next week. The vaccine trial was stopped across four nations as a precautionary measure after one of the recipients in...